breast tumors
HER-2 status did not correlate with pathologic or clinical response (assessed by physical examination or imaging), although a nonsignificant trend was noted toward better response in patients with breast tumors that overexpressed HER-2.
<span class="gene" id="12655533-9-0-5">HER-2</span> status did not correlate with pathologic or clinical response (assessed by physical examination or imaging), although a nonsignificant trend was noted toward better response in patients with <span class="disease" id="12655533-9-197-210">breast tumors</span> that overexpressed <span class="gene" id="12655533-9-230-235">HER-2</span>.